Fintel reports that on March 13, 2025, Jones Trading upgraded their outlook for CervoMed (NasdaqCM:CRVO) from Hold to Buy.

Fintel reports that on March 13, 2025, Chardan Capital upgraded their outlook for CervoMed (NasdaqCM:CRVO) from Neutral to ...

Mind Medicine (MNMD) announced its Q4 financials and indicated it is making strides in developing innovative treatments for ...

Artificial intelligence startup xAI has been the biggest driver of these gains, with its share price surging 110% since Nov. 5, according to Caplight.

Fiserv, Inc. , a leading global provider of payments and financial services technology, has published the Fiserv Small Business Index for February 2025, with the seasonally adjusted Index holding ...

As optimism surrounding China's technological innovation and progress continues to grow, it has emerged as one of the most ...

Best Buy also echoed the price warnings on its own earnings call, telling investors that price increases are “highly likely” ...

President Donald Trump is addressing a joint session of Congress on Tuesday night, six weeks into his historic return to the White House.

But “brain capital ... In America, voters’ sentiment about the economy reliably flips based on their alignment with the president. The Gallup Economic Confidence index highlights this ...

Kennedy has touted the benefits of an unconventional measles treatment including the steroid budesonide, the antibiotic ...

ASX-listed health stocks continue to be battered by geopolitical and economic headwinds, notes Morgans analyst Scott Power.